Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Regado's crew cut

Regado's haircut due to company-specific concerns rather than IPO fatigue

Regado Biosciences Inc. (NASDAQ:RGDO) took a pretty steep haircut to get out the door last month but buysiders say the issues were company-specific and not a sign that appetite for IPOs is waning among public investors.

The sentiment is welcome news for the 17 biotechs still in the IPO

Read the full 489 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE